X0508 4 2024-01-11 0001781174 Acrivon Therapeutics, Inc. ACRV 0001696108 Cuillerot Jean-Marie C/O ACRIVON THERAPEUTICS, INC. 480 ARSENAL WAY, SUITE 100 WATERTOWN MA 02472 true Chief Medical Officer false Stock Option (Right to Buy) 4.82 2024-01-11 4 A 0 99300 0 A 2034-01-10 Common Stock 99300 99300 D Twenty-five percent (25%) of the shares subject to the option shall vest on February 1, 2025, and the remaining shares subject to the option shall vest in 36 substantially equal monthly installments thereafter, in each case subject to the Reporting Person's continuous service through each such vesting date. /s/ Rasmus Holm-Jorgensen, Attorney-in-Fact 2024-01-16